Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Future of manufacturing lies in mobility based manufacturing
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Subscribe To Our Newsletter & Stay Updated